Watchlist Price Alert

Centessa Pharmaceuticals (CNTA)

NASDAQ: CNTA · Real-Time Price · USD

12.60

0.22 (1.78%)

At close: Jun 16, 2025, 3:59 PM

11.93

-5.32%

After-hours: Jun 16, 2025, 07:36 PM EDT

1.78% (1D)

Bid	10.75
Market Cap	1.68B
Revenue (ttm)	n/a
Net Income (ttm)	-223.87M
EPS (ttm)	-1.88
PE Ratio (ttm)	-6.7
Forward PE	-8.37
Analyst	Buy

Ask	13
Volume	996,533
Avg. Volume (20D)	943,403
Open	12.44
Previous Close	12.38
Day's Range	12.15 - 12.69
52-Week Range	8.46 - 19.09
Beta	1.49

About CNTA

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol CNTA

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CNTA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

2 months ago

-8.03%

Centessa Pharmaceuticals shares are trading lower ... Unlock content with Pro Subscription

9 months ago

+12.52%

Centessa Pharmaceuticals shares are trading higher. The company announced it priced a $225 million public offering of 15,254,237 American Depositary Shares at $14.75 per ADS

News

1 day ago · zacks.com

Centessa Pharmaceuticals (CNTA) Upgraded to Buy: What Does It Mean for the Stock?

Centessa Pharmaceuticals (CNTA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

1 week ago · zacks.com

Wall Street Analysts Think Centessa Pharmaceuticals (CNTA) Could Surge 138.77%: Read This Before Placing a Bet

The consensus price target hints at a 138.8% upside potential for Centessa Pharmaceuticals (CNTA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in ...